Profil
Yoh Ito is currently the Chief Financial Officer & Vice President at ActivX Biosciences, Inc. Prior to this, he worked as the Director-Finance & Accounting at KYORIN Pharmaceutical Co. Ltd. (old) and as the Manager-Accounting Finance & IR Contact at KYORIN Pharmaceutical Co., Ltd. from 2012 to 2014.
Mr. Ito holds an MBA from Cornell University and an undergraduate degree from the University of Tokyo.
Postes actifs de Yoh Ito
| Sociétés | Poste | Début |
|---|---|---|
ActivX Biosciences, Inc.
ActivX Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops drug molecule for hematology, oncology, metabolic and inflammatory diseases | Directeur Financier/CFO | - |
Anciens postes connus de Yoh Ito
| Sociétés | Poste | Fin |
|---|---|---|
| KYORIN PHARMACEUTICAL CO., LTD. | Directeur Financier/CFO | - |
KYORIN Pharmaceutical Co. Ltd. (old)
KYORIN Pharmaceutical Co. Ltd. (old) Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Directeur Financier/CFO | - |
Formation de Yoh Ito
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
KYORIN Pharmaceutical Co. Ltd. (old)
KYORIN Pharmaceutical Co. Ltd. (old) Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
ActivX Biosciences, Inc.
ActivX Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops drug molecule for hematology, oncology, metabolic and inflammatory diseases | Health Technology |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Tokyo
University of Tokyo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
KYORIN Pharmaceutical Co., Ltd.
KYORIN Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceuticals through its subsidiaries | Health Technology |
















